tradingkey.logo

Fortrea Holdings Inc

FTRE
查看详细走势图
17.700USD
-0.210-1.17%
收盘 12/24, 13:00美东报价延迟15分钟
1.63B总市值
亏损市盈率 TTM

Fortrea Holdings Inc

17.700
-0.210-1.17%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.17%

5天

+9.33%

1月

+48.12%

6月

+233.33%

今年开始到现在

-5.09%

1年

-5.60%

查看详细走势图

TradingKey Fortrea Holdings Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Fortrea Holdings Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名50/404位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价11.10。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Fortrea Holdings Inc评分

相关信息

行业排名
50 / 404
全市场排名
131 / 4562
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 11 位分析师
持有
评级
11.100
目标均价
-24.90%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Fortrea Holdings Inc亮点

亮点风险
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Fortrea Holdings Inc简介

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
公司代码FTRE
公司Fortrea Holdings Inc
CEOThakrala (Anshul)
网址https://www.fortrea.com/

常见问题

Fortrea Holdings Inc(FTRE)的当前股价是多少?

Fortrea Holdings Inc(FTRE)的当前股价是 17.700。

Fortrea Holdings Inc的股票代码是什么?

Fortrea Holdings Inc的股票代码是FTRE。

Fortrea Holdings Inc股票的52周最高点是多少?

Fortrea Holdings Inc股票的52周最高点是20.260。

Fortrea Holdings Inc股票的52周最低点是多少?

Fortrea Holdings Inc股票的52周最低点是3.970。

Fortrea Holdings Inc的市值是多少?

Fortrea Holdings Inc的市值是1.63B。

Fortrea Holdings Inc的净利润是多少?

Fortrea Holdings Inc的净利润为-328.50M。

现在Fortrea Holdings Inc(FTRE)的股票是买入、持有还是卖出?

根据分析师评级,Fortrea Holdings Inc(FTRE)的总体评级为持有,目标价格为11.100。

Fortrea Holdings Inc(FTRE)股票的每股收益(EPS TTM)是多少

Fortrea Holdings Inc(FTRE)股票的每股收益(EPS TTM)是-11.210。
KeyAI